CareCloud Files Special Meeting Proxy to Accelerate Growth
CareCloud Files Special Meeting Proxy to Accelerate Growth
SOMERSET, N.J., Dec. 09, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company" or "CareCloud") (Nasdaq: CCLD CCLDO, CCLDP), a leader in healthcare information technology solutions for medical practices and health systems nationwide, today announced the solicitation of proxies from its common stock (the "Common Stock") shareholders to approve an increase in its authorized shares. This increase is designed to support the Company's growth initiatives and corporate objectives.
新泽西州索默塞特,2024年12月9日(全球新闻通讯社)—— CareCloud,Inc.(公司或CareCloud)(纳斯达克:CCLD CCLDO, CCLDP)是全国医疗实践和健康系统的医疗信息技术解决方案领导者,今天宣布向其普通股(“普通股”)股东征求代理,以批准增加其授权股份。此增加旨在支持公司的增长计划和企业目标。
Focus on Growth
专注于增长
Mahmud Haq, Founder and Executive Chairman of CareCloud's Board of Directors stated, "As CareCloud's largest common stockholder, Founder and Executive Chairman, I enthusiastically support this proposal. Our board and executive team collectively own more than 38% of the Common Stock and we firmly believe that increasing the number of authorized shares is essential to driving our revenue and profits – empowering us to deliver sustained, double-digit growth with a simultaneous, laser-like focus on profitability."
CareCloud董事会创始人兼执行主席Mahmud Haq表示:“作为CareCloud最大的普通股东,创始人和执行主席,我热情支持这一提案。我们的董事会和管理团队共同持有超过38%的普通股,我们坚信增加授权股份的数量对提升我们的营业收入和利润至关重要——使我们能够实现持续的两位数增长,同时专注于盈利能力。”
CareCloud, a leading developer and provider of healthcare information technology and AI solutions, has achieved a 23% compound annual growth rate ("CAGR") over the past decade through its focus on acquisitive and organic growth. During the first three quarters of 2024, the Company generated over $10 million in free cash flow and achieved a 50% year-over-year increase in adjusted EBITDA.
CareCloud是一家领先的医疗信息技术和人工智能解决方案开发和提供商,在过去十年中,通过专注于收购和有机增长,实现了23%的复合年增长率(“CAGR”)。在2024年的前三个季度,公司产生了超过1000万的自由现金流,并实现了调整后 EBITDA 年同比增长50%。
The Proposal
提案
The board-supported proposal seeks to increase the Company's authorized shares of Common Stock from 35 million to 85 million. This increase is intended to provide the flexibility needed for strategic growth initiatives, including future acquisitions, and to enable the potential conversion of the Company's outstanding Series A Preferred Stock to Common Stock. Additionally, it supports investments in organic growth and other corporate priorities.
董事会支持的提案旨在将公司的授权普通股从3500万增加到8500万。此次增加旨在为战略增长计划提供所需的灵活性,包括未来的收购,并使公司未偿发行的A系列优先股能够转换为普通股。此外,它支持对有机增长和其他企业优先事项的投资。
The Special Meeting of Common Stock Shareholders, which is scheduled for January 27, 2025, will enable holders of the Common Stock as of December 3, 2024 to vote on increasing the Company's authorized shares of Common Stock. Additional information regarding the Proxy is available on the Company's website and at www.sec.gov.
定于2025年1月27日召开的普通股股东特别会议将使截至2024年12月3日的普通股持有者能够对增加公司的授权普通股进行投票。有关委托书的更多信息可在公司的官方网站和www.sec.gov上获取。
How to Vote
如何投票
CareCloud encourages all shareholders to participate and ensure their voices are heard. Shareholders may vote through one of the following methods:
CareCloud鼓励所有股东参与并确保他们的声音被听到。股东可以通过以下任一方式投票:
-
E-Vote: Shareholders may visit the website of the Company's transfer agent () and use the identified control number to vote on or before 11:59 pm Eastern Time on January 23, 2025. Alternatively, they may vote online through their investment broker by following their voting instructions.
-
Mail: Shareholders may mark, sign and date their proxy card, then detach it, and return it in the enclosed postage paid envelope. Proxies must be received by January 23, 2025, to be counted.
- Attend the Special Meeting: Shareholders may attend and vote their shares at the Special Meeting on January 27, 2025.
-
电子投票股东可以访问公司转账代理商的官网(),并使用指定的控制号码在2025年1月23日东部时间晚上11:59之前进行投票。或者,他们可以通过投资经纪商按照其投票说明在线投票。
-
邮寄股东可以在他们的委托票上标记、签名并注明日期,然后将其撕下,并放入随附的已付邮资的信封中寄回。代理投票必须在2025年1月23日之前收到,以便计算。
- 参加特别会议: 股东可以在2025年1月27日的特别会议上出席并投票。
About CareCloud
关于CareCloud
CareCloud brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Learn more about our products and services including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health at .
CareCloud为医疗行业带来了有序的创新。我们的技术解决方案套件帮助客户提高财务和运营绩效,简化临床工作流程并改善患者体验。超过40,000个提供者依靠CareCloud帮助他们改善患者护理,同时减少行政负担和运营成本。了解更多关于我们的产品和服务,包括营业收入管理(RCM)、业务管理(PM)、电子健康记录(EHR)、商业智能、患者体验管理(PXM)和互联网医疗。
Follow CareCloud on LinkedIn, Twitter and Facebook.
关注CareCloud的LinkedIn, 推特 和 Facebook.
Important Additional Information and Where to Find It. CareCloud filed with the SEC a Definitive Proxy Statement on Schedule 14A on December 5, 2024, with respect to its future solicitation of proxies for the Special Meeting of Common Stock Shareholders (including any and all adjournments, postponements, continuations, and reschedulings thereof, the "Special Meeting"). The information contained in this press release is merely a summary of certain relevant portions of the Definitive Proxy Statement and it is important that shareholders review the entirety of the filing. SHAREHOLDERS ARE URGED TO READ THE DEFINITIVE PROXY STATEMENT AND ANY OTHER AMENDMENTS OR SUPPLEMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT CARECLOUD'S FILING. Investors and security holders may obtain copies of these documents and other documents filed with the SEC by CareCloud free of charge through the website maintained by the SEC at www.sec.gov. The Notice of the Special Meeting of Common Stock Shareholders and our Definitive Proxy Statement for the Special Meeting, the Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2024 are available at www.sec.gov.
重要的附加信息及其获取方式。CareCloud于2024年12月5日向美国证券交易委员会(SEC)提交了14A日程的最终代理声明,关于未来对普通股股东特别会议的代理请求(包括任何及所有的休会、推迟、继续和重新安排,"特别会议")。本公告中包含的信息仅为最终代理声明某些相关部分的摘要,股东需要审阅整个文件。强烈建议股东仔细阅读最终代理声明及任何其他向SEC提交的修正案或补充信息,因为它们包含或将包含有关CareCloud提交的相关重要信息。投资者和证券持有人可以通过美国证券交易委员会维护的网站www.sec.gov免费获取这些文件及CareCloud提交的其他文件的副本。普通股股东特别会议的通知及我们的特别会议最终代理声明、截至2023年12月31日的财年10-K表格年度报告和截至2024年9月30日的季度10-Q报告均可在www.sec.gov获取。
Forward-Looking Statements
前瞻性声明
This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as "may," "might," "will," "shall," "should," "could", "intends," "expects," "plans," "goals," "projects," "anticipates," "believes," "seeks," "estimates," "predicts," "possible," "potential," "target," or "continue" or the negative of these terms or other comparable terminology.
这些前瞻性陈述既不是历史事实,也不是对未来业绩的保证。相反,它们仅是预测,具有不确定性,涉及重大的已知和未知的风险,不确定性和其他因素,这些因素可能会导致我们或行业实际结果,活动水平或表现与这些前瞻性陈述所表达的任何未来结果,活动水平或表现实质上不同。即使迄今为止这些陈述与其他内容不同,我们也无持续更新股东有关未来代理或投票趋势的义务。新的风险和不确定性时常出现,我们无法预测所有可能对前瞻性陈述产生影响的风险和不确定性,包括但不限于:公司管理增长的能力,迁移新收效较小的客户和保留新的和现有的客户,保持具有成本效益的全球运营,提高操作效率并降低运营成本,预测并适当地调整与医疗保健行业的变化和其他行业法规和趋势相关的变化,保留关键人员的服务,开发新技术,升级并使遗留的和收购的技术适应与不断发展的行业标准的工作,与在竞争对手产品和服务方面具有竞争力的其他公司争夺,以及在公司的SEC备案中参考和讨论的其他重要风险和不确定性。
Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, the impact of pandemics on our financial performance and business activities, and the expected results from the integration of our acquisitions.
我们业务涉及的风险和不确定性很多,其中许多都超出了我们的控制能力,或是其中的一个或多个就能对我们的业绩产生实质性影响,即便是前瞻性陈述最终被证明是正确的。在本新闻稿中,前瞻性陈述包括,但不仅限于,反映管理层对未来的财务表现和营运费用、预期增长、盈利能力和业务前景,疫情对我们的财务表现和业务活动的影响以及我们的收购的预期成果。这些前瞻性声明既不是历史事实,也不是未来业绩的保证,而是预测未来,不确定的,涉及实质性已知和未知的风险、不确定性和其他因素,这些风险、不确定性和其他因素可能使我们(或我们所处的行业)的实际结果、活动数量或业绩与这些前瞻性声明所表达或暗示的未来结果、活动数量或业绩有很大的不同。我们不必为未来的委托或投票趋势更新股东,即使它们与迄今为止的情况有很大的不同。新的风险和不确定性时有出现,我们无法预测将会对前瞻性陈述产生影响的所有风险和不确定性,这些包括但不仅限于,公司管理增长、迁移新获得的客户和保留新老客户、保持全球经营成本、提高运营效率并降低运营成本、预测和适应报销和其他行业的规定和趋势的变化、保留关键人员的服务、开发新的技术、升级和适应遗留和已获得的技术符合不断发展的行业标准、与竞争对手公司的产品和服务进行竞争等重要的风险和不确定性,详见公司向证券交易委员会提出的名为“风险因素”的文件。
These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry's) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company's ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies' products and services competitive with ours, and other important risks and uncertainties referenced and discussed under the heading titled "Risk Factors" in the Company's filings with the Securities and Exchange Commission.
这些前瞻性声明既不是历史事实,也不是对未来业绩的保证。相反,它们仅仅是预测,具有不确定性,并涉及大量已知和未知的风险、不确定性以及其他因素,这些因素可能导致我们(或我们行业的)实际结果、活动水平或业绩与这些前瞻性声明所表达或暗示的任何未来结果、活动水平或业绩有实质性差异。新的风险和不确定性不时出现,我们无法预测所有可能对前瞻性声明产生影响的风险和不确定性,包括但不限于,与公司管理增长的能力、新获取客户的迁移和新旧客户的保持、维持具有成本效益的全球运营、提高运营效率和降低运营成本、预测并适当地调整对报销及其他行业法规和趋势的变化、保留关键人员的服务、开发新技术、升级和调整遗留和获得的技术以适应不断发展的行业标准、与其他公司具有竞争性的产品和服务竞争,以及在公司向证券交易委员会提交的文件中提到和讨论的“风险因素”标题下的其他重要风险和不确定性。
The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.
本新闻稿中的声明是在本新闻稿的日期上其发布,即使稍后在公司的网站上或以其他方式提供或公开,公司也不承担更新向前看陈述的义务,以反映发生的事件或存在的情况。
SOURCE CareCloud
消息来源CareCloud
Company Contact:
Norman Roth
Interim Chief Financial Officer and Corporate Controller
CareCloud, Inc.
nroth@carecloud.com
公司联系人:
Norman Roth
临时首席财务官和企业控制器
CareCloud, Inc.
nroth@carecloud.com
Investor Contact:
Stephen Snyder
President
CareCloud, Inc.
ir@carecloud.com
投资者联系:
Stephen Snyder
总裁
CareCloud,Inc.
ir@carecloud.com